Variant report
Variant | esv13414 |
---|---|
Chromosome Location | chr4:21782010-21782635 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7681415 | chr4:21782045-21782046 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574750323 | chr4:21782070-21782071 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542121125 | chr4:21782088-21782089 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181166005 | chr4:21782094-21782095 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529916233 | chr4:21782143-21782144 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549650912 | chr4:21782219-21782220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186391317 | chr4:21782242-21782243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs386672436 | chr4:21782268-21782269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6448080 | chr4:21782334-21782335 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs386672437 | chr4:21782340-21782341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114443724 | chr4:21782341-21782342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374053707 | chr4:21782374-21782375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191812512 | chr4:21782388-21782389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528941232 | chr4:21782399-21782400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547703081 | chr4:21782455-21782456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565996719 | chr4:21782459-21782460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34379638 | chr4:21782475-21782476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6448082 | chr4:21782493-21782494 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs551574455 | chr4:21782500-21782501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369160677 | chr4:21782515-21782516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534371057 | chr4:21782537-21782538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35161937 | chr4:21782583-21782584 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs116300661 | chr4:21782584-21782585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6448083 | chr4:21782597-21782598 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535498101 | chr4:21782604-21782605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138842390 | chr4:21782618-21782619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6448084 | chr4:21782619-21782620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21781000-21782800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr4:21781800-21782400 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr4:21781800-21782600 | Enhancers | NH-A | brain |
4 | chr4:21781800-21782600 | Enhancers | Osteobl | bone |
5 | chr4:21781800-21783200 | Enhancers | HUVEC | blood vessel |
6 | chr4:21782000-21782200 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |